Sponsored by

Genentech Biooncology

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 51 to 75 of about 6087

Previous 25

Website Changes

06/15/2026

TBI Linked to Higher Brain Cancer Mortality Risk

06/15/2026

MAGMAS Inhibition Enhances Temozolomide Efficacy in Chemotherapy-Resistant Glioblastoma Models

06/08/2026

Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastoma

06/08/2026

Personalized machine learning-guided radiation dose escalation in newly diagnosed glioblastoma: prospective pilot study

06/08/2026

MRI-guided adaptive radiotherapy for high grade glioma (UNITED): a single-centre, single-arm, non-inferiority, phase 2 trial

06/08/2026

Researchers Uncover How an Aggressive Brain Tumor Evades Treatment

06/01/2026

More news from ASCO 2026

06/01/2026

Research Spotlight: External Controls Show Promise for Use in Glioblastoma Clinical Trials

06/01/2026

Copayment assistance program is now open!

06/01/2026

Chapter 132: Why can’t she just get over it?

06/01/2026

Implanted Tile-Based Radiation Outperforms Stereotactic Radiotherapy for Treatment of Brain Metastases

06/01/2026

Localized Synergistic Nanofibers Could Eliminate Glioblastoma

05/18/2026

Personalized vaccine shows promise against aggressive brain cancer

05/18/2026

Horizons in Neuro-oncology Webinar this week

05/18/2026

Alpha Tau Announces Groundbreaking Interim Results from its U.S. Alpha DaRT Recurrent Glioblastoma Trial

05/11/2026

NIH-funded study suggests that testosterone suppresses brain tumor growth in males

05/10/2026

Webinar tomorrow!

05/10/2026

The Scientist Designing a Tailored Attack on Glioblastoma

05/04/2026

Webinar next week!

04/27/2026

Brown Health researchers identify key molecule behind `exceptional responders` with glioblastoma

04/27/2026

Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial

04/27/2026

5th Annual Tumor Takedown Event in Florida!

04/20/2026

IL-6 underlies microenvironment immunosuppression and resistance to therapy in glioblastoma

04/13/2026

Trogenix announces publication of breakthrough pre-clinical data in Nature demonstrating complete tumour eradication and durable protection in aggressive brain cancer model

04/13/2026

Wearable Technology`s Growing Role in Monitoring Brain Health

Our Terms of Use and Privacy Policy has changed.
Click HERE to read it!